Tulip Lab Private limited proudly announces commissioning of its Pharmaceutical & Herbal medicine R&D Centre. PLATFORM TECHNOLOGIES: Microspheres Liposomal Technology Sustained Release Formulation Technology Orally Disintegrating Tablet Technology Inhalation Technology Effervescent Technology Taste Masking Technology Nanoparticles Lyophilization Technology R&D Equipped with: Formulation Lab Analytical Lab Modern Analytical Equipments Geared To Develop: *Novel Drug Delivery System -Microspheres -Liposomes -Buccal Tablets -Sustained Release Matrix Tablets -Nanoparticles * Oral Solids:Tablets -Film Coated Tablets -Enteric Coated Tablets -Chewable Tablets -Mouth Dissolving tablets -Effervescent Tablets -Dispersible Tablets *Oral Liquids -Syrups -Suspension -Elixirs *Dosage Form for External Use *Solution for External use *External Powder *Mouth Wash/Gargles *Other Dosage Forms -Ear Drops -Nasal Drops Catering to needs of clients in: -Regulated Markets -Semi Regulated Market (ROW) -Domestic Market Additional activities for partners: *Formulation -Troubleshooting of existing products -Process improvement -Cost reduction in existing formulation *Analytical -Analytical method validation for -Assay -Dissolution -Related Substances -Residual Solvents -Development of cost effective analytical methods. -Troubleshooting of analytical methods Connect with : Mr.Vishal Chandra General Manager-International Business e-mail: vishal@tlplindia.com, mobile:+91-9167770803 Skype:vishalukraine

1. RESEARCH AND DEVELOPMENT CENTRE
TULIP LAB PRIVATE LTD.
Bang on Target….
Files 3 Patents
Connect with : Vishal Chandra
General Manager- International Business
E-mail: vishalvnso4@yahoo.co.in Mobile/Viber/Whatsaap:+91-9167770803
Skype:vishalukraine

2. 2
R&D Location
R&D Centre, Tulip
Lab. Pvt. Ltd.

3. DSIR Recognition
DSIR recognition valid up to 31/03/2016
F. No. TU/IV-RD/3064/2013
3

4. Strength: Vertical Integration
44
 R&D Centre equipped with modern research
infrastructure.
 Ability to formulate and market drugs in the shortest
possible lead time
 Team of competent analytical experts.
WHO GMP & PIC/S approved manufacturing unit
for validation & Commercial batches.
HACCP, ISO, HALAL accredited facility.

5. R&D Team
55
Doctorate: 03
Post Graduates: 10
Lab Technicians: 03

6. Platform Technologies
Microspheres
Liposomal Technology
Sustained Release Formulation Technology
Orally Disintegrating Tablet Technology
Inhalation Technology
Effervescent Technology
Taste Masking Technology
Nanoparticles
Lyophilization Technology
66

7. Achievements
Filed three Indian Patents
10+ National and International publications
Contribution in the modification of Analytical Method in
British Pharmacopoeia( Propanolol)
77

8. Achievements
 Patents
 Complete Patent Application
 Formulation of Metformin
Appl. No.: 3069/MUM/2014
Date : 25/09/2014
 Provisional Patent Applications
 Stable Pharmaceutical Formulation of Montelukast Sodium and
Levocetirizine Dihydrochloride
Appl. No.: 105/MUM/2014
Date : 13/01/2014
 Stable Combination of Aceclofenac and Thiocolchicoside
Appl. No.: 460/MUM/2014.
Date : 10/02/2014
Contd
88

9. Achievements
 Discrepancy in the pharmacopoeia method of related substances for
Propranolol Tablets is communicated with Expert Advisory Group
(EAG) of British Pharmacopoeia. Proposed method is accepted by
MHRA and EAG.
 Received Letter of Intent from Expert Advisory Group (EAG) of British
Pharmacopoeia for the proposed analytical method of related
substances in Propranolol Tablets.
99

10. 10
http://apps.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2012/09/002965
http://apps.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2012/09/002954
http://apps.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2012/09/002950
http://apps.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2009/091/000605
Achievements

11. Publications
 Published research article as “ Fast disintegrating tablets containing Cassia angustifolia
(Senna), in American Journal of Pharmtech Research 2015;5(2):547-554
 Published a clinical study as “An open label, prospective clinical study to evaluate the
efficacy and safety of ‘TLPL/AY/01/2008’ in the management of functional constipation”
in Journal of Ayurveda and Integrative Medicine 2011;2(3):144-152.
 Published toxicity study as “Acute and 28-day repeated dose toxicity studies with
polyherbal formulation of Isabgol Husk, Swarnapatri leaf extract and Triphala fruits
extracts (TLPL/AY/01/2008)” in International Journal of Pharma and Bio-Sciences
2011;2(4):639-652.
1111

12. Publications
 “An open label, prospective, clinical study on a polyherbal formulation in osteoarthritis of
knee”. Journal of Ayurveda and Integrative Medicine 2013; 4(1): 33–39.
 “ Safety Assessment of TLPL/AY/03/2008, A Polyherbal Formulation in Sprague Dawley
Rats. Toxicology International 2013; 20(1): 77–86.
 “RP-HPLC Method for simultaneous constitution of boeravinone E and boeravinon B in
Boerhaavia diffusa extract and its formulation” in Journal of Natural Product research
2012:1:14
 “Design and development of a stable polyherbal formulation based on the results of
compatibility studies” in Journal of Parmacology research 2011:3(2):122-9.
 “A novel approach for the quality assessment and Stability testing of Ayurvedic
polyherbal formulations by HPTLC fingerprint method” in Journal of Liquid
Chromatography & Related Technologies 2011;34:579-90.
Contd
1212

13. R&D Equipped with:
 Formulation Lab:
 Rapid Mixer Granulator (General Machinery)
 Tray Dryer (General Machinery)
 Fluid Bed Dryer (Retsch)
 Compression Machine (Fluid Pack)
 Semi Automatic Coating Pan
 Capsule Filling Machine
 Tap Density Apparatus (Electrolab)
 Disintegration Test Apparatus (Electrolab)
 Hardness Tester (Electrolab)
 Friability Tester (Electrolab)
1313
Contd

14.  Vernier Caliper (Mitutoyo)
 Colloidal Mill (Chamunda)
 IR Moisture Analyzer (Sartorius)
 Dehumidifier (Tropical Nortec)
 Multipurpose Equipment (Kalweka)
 Dry Granulator
 Double Cone Blender
 Planetary Mixer
 Universal Gearing
 Wet Granulator/Oscillating Granulator
1414
Contd
R&D Equipped with:
 Analytical Lab

15.  Analytical Equipment's
 HPLC (Waters) 2 Nos.
 Lyophilizer (Vertis)
 HPTLC with scanner (Camag)
 UV lamp cabinet (Camag)
 Dissolution Apparatus (Electrolab)
 Rotavapour (Buchi India)
 Water Bath (Expo-Hitech)
 Muffle furnace
1515
Contd
R&D Equipped with:

16.  Digital pH meter (LabIndia)
 Milipore Water filtration unit (Milipore)
 Ultra Sonicator (Equiton)
 Refrigerators
 Stability Chambers (Thermlab)
 Hot air Oven (Thermolab)
1616
 Analytical Equipment’s
R&D Equipped with:

17. Geared to Develop:
 Novel Drug Delivery System
 Microspheres
 Liposomes
 Buccal Tablets
 Sustained Release Matrix Tablets
 Nanoparticles
 Oral Solids
 Tablets

Film Coated Tablets

Enteric Coated Tablets

Chewable Tablets

Mouth Dissolving tablets

Effervescent Tablets

Dispersible Tablets
Contd
1717

18.  Hard gelatin Capsules
 Oral Powder
 Dry Syrup
 Semisolids
 Ointments
 Creams
 Gel
 Parenterals
 Lyophilized powder for injection
 Lyophilized powder for infusion
 Injections (Terminally sterilized)
 Eye Drops
Contd
1818
Dosage form which can be Developed:

19.  Oral Liquids
 Syrups
 Suspension
 Elixirs
 Dosage Form for External Use
 Solution for External use
 External Powder
 Mouth Wash/Gargles
 Other Dosage Forms
 Ear Drops
 Nasal Drops
1919
Dosage forms which can be Developed

20.  Regulated Markets
 Semi Regulated Market (ROW)
 Domestic Market
2020
Catering to needs of clients in:
Additional activities for partners
Formulation
Troubleshooting of existing products
Process improvement
Cost reduction in existing formulation

21. Undertake assignments from Clients:
21
Analytical
Analytical method validation for
Assay
Dissolution
Related Substances
Residual Solvents
Development of cost effective analytical methods.
Troubleshooting of analytical methods
21

22. 22
Thank You
22
Connect With:
* Mr. Sai Shivram
Head Research & Development Department
e-mail: sai.s@tlplindia.com
* Mr. Vishal Chandra
General Manager- International Business
e-mail: vishal@tlplindia.com
Mobile/Whatsaap/Viber:+91-9167770803
Skype: vishalukraine